Alpha DNA Investment Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,752
Closed -$473K 146
2024
Q4
$473K Buy
+13,752
New +$473K 0.18% 115
2024
Q3
Sell
-7,340
Closed -$442K 245
2024
Q2
$442K Sell
7,340
-4,442
-38% -$267K 0.17% 135
2024
Q1
$608K Sell
11,782
-1,383
-11% -$71.3K 0.22% 97
2023
Q4
$531K Sell
13,165
-7,714
-37% -$311K 0.21% 109
2023
Q3
$582K Buy
+20,879
New +$582K 0.24% 91